Kestra Medical Technologies Ltd (KMTS) Q2 2026 Earnings Call Highlights: Revenue Surge and ... [Yahoo! Finance]
Kestra Medical Technologies, Ltd. (KMTS)
Company Research
Source: Yahoo! Finance
Gross Margin: 50.6%, up from 39.6% in the prior year period. Operating Expenses: $43.2 million, including $1 million of non-recurring costs. Net Loss: GAAP net loss of $32.8 million, compared to $20.6 million in the prior year period. Adjusted EBITDA Loss: $19.7 million, compared to $16.1 million in the prior year period. Cash and Cash Equivalents: $175.4 million as of October 31, 2025. Revenue Guidance for FY 2026: Increased to $91 million, representing 52% growth compared to FY 2025. Warning! GuruFocus has detected 3 Warning Sign with KMTS. Is KMTS fairly valued? Test your thesis with our free DCF calculator. Release Date: December 11, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript Kestra Medical Technologies Ltd ( NASDAQ:KMTS ) reported a 53% increase in revenue for the second quarter, reaching $22.6 million, driven by a 54% year-over-year increase in prescriptions. The company's gross margin surpassed
Show less
Read more
Impact Snapshot
Event Time:
KMTS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KMTS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KMTS alerts
High impacting Kestra Medical Technologies, Ltd. news events
Weekly update
A roundup of the hottest topics
KMTS
News
- Kestra Medical Technologies (NASDAQ:KMTS) had its "neutral" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..MarketBeat
- Kestra Medical Technologies (NASDAQ:KMTS) was given a new $30.00 price target on by analysts at Stifel Nicolaus.MarketBeat
- Kestra Medical Technologies (NASDAQ:KMTS) had its "overweight" rating reaffirmed by analysts at Piper Sandler.MarketBeat
- Kestra Medical Technologies (NASDAQ:KMTS) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.MarketBeat
- Kestra Medical (KMTS) Q2 2026 Earnings Transcript [Yahoo! Finance]Yahoo! Finance
KMTS
Earnings
- 12/11/25 - Miss
KMTS
Sec Filings
- 12/11/25 - Form 10-Q
- 12/11/25 - Form 8-K
- 12/4/25 - Form 4
- KMTS's page on the SEC website